Can a Cancer-Preventing vaccine work for transplant patients?
NCT ID NCT03036930
Summary
This study is testing whether the HPV vaccine, which helps prevent certain cancers, can still help build a strong immune response in people who are about to receive a kidney transplant. Kidney transplant patients must take powerful drugs to prevent organ rejection, but these drugs weaken the immune system. Researchers want to see if giving the vaccine before the transplant helps the body maintain protection against HPV-related cancers even after starting these medications. The study involves 51 adults who will receive the vaccine at least 30 days before their transplant surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
UCSF Medical Center-Mount Zion
San Francisco, California, 94115, United States
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
-
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.